Replies to post #22729 on OncoSec Medical Inc (ONCSQ)

[Tinh2p]

stormin normin, its just not about the mice data. it's about how the mice data correlates with the data from the phase 2 human trial. if they can make a solid presumption or hypothesis with data supporting turning non responders into responders then that imo would be enough to move the stock price. The key is to have solid data from both mice and patient to support their hypothesis. eom

[furbush87]

I can not give you the name of the stock, but there was a bio stock last year that went up 200% on pre phase 1 computer results. It was a bogus pump on a stock with low float, but it did happen.